OUR CLINICAL RESEARCH EXPERIENCE

• Phase III Manic Episodes Associated with Bipolar I Disorder Study, 267 patients recruited globally, 3 sites in Turkey
• Phase III Manic Episodes Associated with Bipolar I Disorder Study, 435 patients recruited globally, 3 sites in Turkey.
• Phase IIIb Complicated Intra-Abdominal Infections Study, 400 patients recruited globally, 5 sites in Turkey.
• Phase IIIb Complicated Skin and Skin Structure Infections in Hospitalized Patients Treatment Study, 400 patients recruited globally, 5 sites in Turkey.
• Phase IIIb Metastatic Breast Cancer Study, 5 sites in Turkey.
• Phase IIIb Renal Cell Carcinoma Study, 5 sites in Turkey.
• Phase IIIa Schizophrenia Study, 10 patients recruited locally, 6 sites in Turkey.
• Phase IIIb End-Stage Renal Failure on Chronic Haemodialysis Treatment Study, 23 patients recruited locally, 4 sites in Turkey.

• Phase IIIb Prostate Cancer Study, 8000 patients recruited globally, 3 sites in Turkey.
• Phase II Diffuse Large B-Cell Lymphoma (DLBCL)Study, 3 sites in Turkey.
• Phase IV Cervical Dystonia Study, 4 sites in Turkey.
• Phase III cIAI and Antibiotic Study, 430 patients recruited globally, 2 sites in Turkey.
• Phase III CSSSI and  Antibiotic Study, 500 patients recruited globally, 2 sites in Turkey.
• Phase IIIb Paediatric CKD and Antihypertensive Study, 419 patients recruited globally, 5 sites in Turkey.
• Phase IIIb Prostate CancerStudy, 8000 patients recruited globally, 3 sites in Turkey.
• Phase IIIb Antihypertensive Study, 800 patients recruited globally, 3 sites in Turkey.
• Phase IIIb Parkinson Disease Study, 1300 patients recruited globally, 5 sites in Turkey.
• Phase IIIa Multiple Sclerosis Study, 1500 patients recruited globally, 5 sites in Turkey.
• Phase III Breast Cancer Study, 3500 patients recruited globally, 5 sites in Turkey.
• Phase II/III Metastatic Colorectal Cancer Study, 1600 patients recruited globally, 5 sites in Turkey.
• Phase III Breast Cancer Study, 1700 patients recruited globally, 6 sites in Turkey. 
• Phase III Breast Cancer Imaging Study, 2500 patients recruited globally.
• Phase III 3rd Line Metastatic Colorectal CancerStudy, 1200 patients recruited globally, 6 sites in Turkey.
• Phase III Lipid Control and Vascular Disease Study, 4200 patients recruited globally,  9 sites in Turkey.
• Phase III Lipid Control and Vascular Disease Study, 1200 patients recruited globally, 12 sites in Turkey.
• Phase III Metastatic Breast CancerStudy, 2500 patients recruited globally, 8 sites in Turkey.
• Phase II Multiple Sclerosis Study, 3000 patients recruited globally, 6 sites in Turkey.
• Phase II Pediatric Neurology Study, 54 patients recruited globally, 1 site in Turkey.
• Observational Neurology Study, 3000 patients recruited globally, 4 sites in Turkey.
• Phase IIIa Psychiatry Study, 1500 patients recruited globally, 4 sites in Turkey.
• Phase IIIb Psychiatry Study, 1000 patients recruited globally, 4 sites in Turkey.
• Phase III Gynecology Study, 400 patients recruited globally, 6 sites in Turkey
• Observational Restrospective Non-Small Cell Lung Cancer Study, 4000 patients recruited globally, 4 sites in Turkey.
• Observational Prospective Non-Small Cell Lung Cancer Study, 2000 patients recruited globally, 4 sites in Turkey.
• Phase III Hepatocellular Carcinoma Study, 1200 subjects recruited globally, 3 sites in Turkey. 
• Phase III Adolescent Schizophrenia Study, 400 patients recruited globally, 3 sites in Turkey.
• Phase II Duchenne Muscular Dystrophy Study, 70 patients recruited globally, 1 site in Turkey
• Phase II Hepatocellular Carcinoma Study, 250 patients recruited globally, 1 site in Turkey.
• Observational Neuro modulation Study, 700 patients recruited globally, 5 sites in Turkey.
• Observational Deep Brain Stimulation Study, 35 patients recruited globally, 1 site in Turkey.
• Phase III Complicated Intra abdominal Infection Study, 800 patients recruited globally, 4 sites in Turkey
• Phase III Complicated Skin and Soft Tissue Infection Study, 1100 patients recruited globally, 6 sites in Turkey
• Phase III Pediatric Equinus Foot Deformity Study, 900 patients recruited globally, 6 sites in Turkey.
• Phase III Study Of Diabetic Nephropathy 2168 patients recruited globally, 5 sites in Turkey
 • Phase III Study of Pediatric Upper Limb Spasticity, 4 sites in Turkey
• Observational Study of Invasive Candida Infection, 7 sites in Turkey
• Observational Relapsing-Remitting Multiple Sclerosis Study, 953 patients recruited globally, 6 sites in Turkey
• Phase III Pediatric Osteomyelitis Study, 8 sites in Turkey
• Phase IIIb Active Axial Spondyloarthritis Study, 6 sites in Turkey   • Observational Retrospective Commander (Cobalt Chromium) stent study, 2 sites in Turkey
• Observational Coronary Artery Disease Study, 2 sites in Turkey
• Phase II Allergic Rhinitis Study, 2 sites in Turkey.
• Observational Gastro-oesophageal reflux disease Study, 10 sites in Turkey
• Observational Prospective Neurovascular Study, 2 sites in Turkey
• Observational Coroner Artery Disease Study, 10 sites in Turkey
• Phase II Subacute Sclerosing Panencephalitis (SSPE) Disease Study (sponsored by TUBITAK), 1 site in Turkey

• Phase II Subacute Sclerosing Panencephalitis (SSPE) Disease Study (sponsored by TUBITAK), 1 site in Turkey
• Phase II Allergic Rhinitis Study, 2 sites in Turkey
• Phase II Hepatocellular Carcinoma Study, 250 patients recruited globally, 1 site in Turkey.
• Phase II Duchenne Muscular Dystrophy Study, 70 patients recruited globally, 1 site in Turkey
• Phase II Pediatric Neurology Study, 54 patients recruited globally, 1 site in Turkey.
• Phase II Multiple Sclerosis Study, 3000 patients recruited globally, 6 sites in Turkey.
• Phase II/III Metastatic Colorectal Cancer Study, 1600 patients recruited globally, 5 sites in Turkey.
• Phase II Diffuse Large B-Cell Lymphoma (DLBCL)Study, 3 sites in Turkey.
• Phase II Multiple Sclerosis Study, 3000 patients recruited globally, 6 sites in Turkey.
• Phase II Pediatric Neurology Study, 54 patients recruited globally, 1 site in Turkey.
• Phase II Duchenne Muscular Dystrophy Study, 70 patients recruited globally, 1 site in Turkey
• Phase II Hepatocellular Carcinoma Study, 250 patients recruited globally, 1 site in Turkey.
• Phase II Allergic Rhinitis Study, 2 sites in Turkey
• Phase II Subacute Sclerosing Panencephalitis (SSPE) Disease Study (sponsored by TUBITAK), 1 site in Turkey

• Phase III Manic Episodes Associated with Bipolar I Disorder Study, 267 patients recruited globally, 3 sites in Turkey
• Phase III Manic Episodes Associated with Bipolar I Disorder Study, 435 patients recruited globally, 3 sites in Turkey.
• Phase IIIb Complicated Intra-Abdominal Infections Study, 400 patients recruited globally, 5 sites in Turkey.
• Phase IIIb Complicated Skin and Skin Structure Infections in Hospitalized Patients Treatment Study, 400 patients recruited globally, 5 sites in Turkey.
• Phase IIIb Metastatic Breast Cancer Study, 5 sites in Turkey.
• Phase IIIb Renal Cell Carcinoma Study, 5 sites in Turkey.
• Phase IIIa Schizophrenia Study, 10 patients recruited locally, 6 sites in Turkey.
• Phase IIIb End-Stage Renal Failure on Chronic Haemodialysis Treatment Study, 23 patients recruited locally, 4 sites in Turkey.
• Phase IIIb Prostate Cancer Study, 8000 patients recruited globally, 3 sites in Turkey.
Phase IIIb End-Stage Renal Failure on Chronic Haemodialysis Treatment Study, 23 patients recruited locally, 4 sites in Turkey.
• Phase IIIb Prostate Cancer Study, 8000 patients recruited globally, 3 sites in Turkey.
Phase III cIAI and Antibiotic Study, 430 patients recruited globally, 2 sites in Turkey.
• Phase III CSSSI and Antibiotic Study, 500 patients recruited globally, 2 sites in Turkey.
• Phase IIIb Paediatric CKD and Antihypertensive Study, 419 patients recruited globally, 5 sites in Turkey.
• Phase IIIb Prostate CancerStudy, 8000 patients recruited globally, 3 sites in Turkey.
• Phase IIIb Antihypertensive Study, 800 patients recruited globally, 3 sites in Turkey.
• Phase IIIb Parkinson Disease Study, 1300 patients recruited globally, 5 sites in Turkey.
• Phase IIIa Multiple Sclerosis Study, 1500 patients recruited globally, 5 sites in Turkey.
• Phase III Breast Cancer Study, 3500 patients recruited globally, 5 sites in Turkey.
• Phase II/III Metastatic Colorectal Cancer Study, 1600 patients recruited globally, 5 sites in Turkey.
• Phase III Breast Cancer Study, 1700 patients recruited globally, 6 sites in Turkey.
• Phase III Breast Cancer Imaging Study, 2500 patients recruited globally.
Phase III 3rd Line Metastatic Colorectal CancerStudy, 1200 patients recruited globally, 6 sites in Turkey.
• Phase III Lipid Control and Vascular Disease Study, 4200 patients recruited globally, 9 sites in Turkey.
• Phase III Lipid Control and Vascular Disease Study, 1200 patients recruited globally, 12 sites in Turkey.
• Phase III Metastatic Breast CancerStudy, 2500 patients recruited globally, 8 sites in Turkey.
Phase IIIa Psychiatry Study, 1500 patients recruited globally, 4 sites in Turkey.
• Phase IIIb Psychiatry Study, 1000 patients recruited globally, 4 sites in Turkey.
• Phase III Gynecology Study, 400 patients recruited globally, 6 sites in Turkey
• Phase III Hepatocellular Carcinoma Study, 1200 subjects recruited globally, 3 sites in Turkey.
• Phase III Adolescent Schizophrenia Study, 400 patients recruited globally, 3 sites in Turkey
• Phase III Complicated Intra abdominal Infection Study, 800 patients recruited globally, 4 sites in Turkey
• Phase III Complicated Skin and Soft Tissue Infection Study, 1100 patients recruited globally, 6 sites in Turkey
• Phase III Pediatric Equinus Foot Deformity Study, 900 patients recruited globally, 6 sites in Turkey.
• Phase III Study Of Diabetic Nephropathy 2168 patients recruited globally, 5 sites in Turkey
• Phase III Study of Pediatric Upper Limb Spasticity, 4 sites in Turkey
Phase III Pediatric Osteomyelitis Study, 8 sites in Turkey
• Phase IIIb Active Axial Spondyloarthritis Study, 6 sites in Turkey

• Phase IV Cervical Dystonia Study, 4 sites in Turkey.

• Observational Restrospective Non-Small Cell Lung Cancer Study, 4000 patients recruited globally, 4 sites in Turkey.
• Observational Prospective Non-Small Cell Lung Cancer Study, 2000 patients recruited globally, 4 sites in Turkey.
• Observational Neuro modulation Study, 700 patients recruited globally, 5 sites in Turkey.
• Observational Deep Brain Stimulation Study, 35 patients recruited globally, 1 site in Turkey.
• Observational Study of Invasive Candida Infection, 7 sites in Turkey
• Observational Relapsing-Remitting Multiple Sclerosis Study, 953 patients recruited globally, 6 sites in Turkey
• Observational Retrospective Commander (Cobalt Chromium) stent study, 2 sites in Turkey
• Observational Coronary Artery Disease Study, 2 sites in Turkey
• Observational Gastro-oesophageal reflux disease Study, 10 sites in Turkey
• Observational Prospective Neurovascular Study, 2 sites in Turkey
• Observational Coroner Artery Disease Study, 10 sites in Turkey

TOP